Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1907857457;57458;57459 chr2:178597938;178597937;178597936chr2:179462665;179462664;179462663
N2AB1743752534;52535;52536 chr2:178597938;178597937;178597936chr2:179462665;179462664;179462663
N2A1651049753;49754;49755 chr2:178597938;178597937;178597936chr2:179462665;179462664;179462663
N2B1001330262;30263;30264 chr2:178597938;178597937;178597936chr2:179462665;179462664;179462663
Novex-11013830637;30638;30639 chr2:178597938;178597937;178597936chr2:179462665;179462664;179462663
Novex-21020530838;30839;30840 chr2:178597938;178597937;178597936chr2:179462665;179462664;179462663
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACA
  • RefSeq wild type template codon: TGT
  • Domain: Fn3-26
  • Domain position: 91
  • Structural Position: 124
  • Q(SASA): 0.1422
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I rs1452086800 0.455 0.294 N 0.68 0.196 0.324986149311 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 3.27E-05 None 0 0 0
T/I rs1452086800 0.455 0.294 N 0.68 0.196 0.324986149311 gnomAD-4.0.0 1.59238E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.4334E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.0701 likely_benign 0.0677 benign -0.159 Destabilizing 0.005 N 0.235 neutral N 0.428048799 None None N
T/C 0.3606 ambiguous 0.3886 ambiguous -0.519 Destabilizing 0.989 D 0.644 neutral None None None None N
T/D 0.2996 likely_benign 0.2786 benign -0.224 Destabilizing 0.524 D 0.682 prob.neutral None None None None N
T/E 0.2526 likely_benign 0.2225 benign -0.317 Destabilizing 0.355 N 0.676 prob.neutral None None None None N
T/F 0.3039 likely_benign 0.3023 benign -0.849 Destabilizing 0.794 D 0.676 prob.neutral None None None None N
T/G 0.167 likely_benign 0.1663 benign -0.188 Destabilizing 0.185 N 0.597 neutral None None None None N
T/H 0.2692 likely_benign 0.2474 benign -0.273 Destabilizing 0.96 D 0.637 neutral None None None None N
T/I 0.1933 likely_benign 0.1725 benign -0.196 Destabilizing 0.294 N 0.68 prob.neutral N 0.490769339 None None N
T/K 0.1851 likely_benign 0.1473 benign -0.403 Destabilizing 0.003 N 0.45 neutral N 0.495620585 None None N
T/L 0.1066 likely_benign 0.1014 benign -0.196 Destabilizing 0.003 N 0.425 neutral None None None None N
T/M 0.0945 likely_benign 0.0967 benign -0.3 Destabilizing 0.794 D 0.657 prob.neutral None None None None N
T/N 0.1105 likely_benign 0.1022 benign -0.223 Destabilizing 0.524 D 0.633 neutral None None None None N
T/P 0.0781 likely_benign 0.0676 benign -0.163 Destabilizing 0.627 D 0.772 deleterious N 0.486001024 None None N
T/Q 0.2033 likely_benign 0.1797 benign -0.416 Destabilizing 0.794 D 0.781 deleterious None None None None N
T/R 0.1876 likely_benign 0.1524 benign -0.098 Destabilizing 0.294 N 0.723 deleterious N 0.473820639 None None N
T/S 0.0929 likely_benign 0.0912 benign -0.364 Destabilizing 0.013 N 0.332 neutral N 0.409308322 None None N
T/V 0.1435 likely_benign 0.1365 benign -0.163 Destabilizing 0.185 N 0.507 neutral None None None None N
T/W 0.6112 likely_pathogenic 0.6231 pathogenic -0.964 Destabilizing 0.989 D 0.67 prob.neutral None None None None N
T/Y 0.3389 likely_benign 0.329 benign -0.645 Destabilizing 0.96 D 0.662 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.